Results 31 to 40 of about 464,460 (389)
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.
Importance Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) and request elective surgery or procedure present a common clinical situation yet perioperative management is uncertain. Objective To investigate the safety of
J. Douketis+30 more
semanticscholar +1 more source
Prediction Score for Anticoagulation Control Quality Among Older Adults
BackgroundTime in the therapeutic range (TTR) is associated with the effectiveness and safety of vitamin K antagonist (VKA) therapy. To optimize prescribing of VKA, we aimed to develop and validate a prediction model for TTR in older adults taking VKA ...
Kueiyu Joshua Lin+8 more
doaj +1 more source
Anticoagulants for acute ischaemic stroke [PDF]
Peer reviewedPublisher ...
Counsell, Carl+2 more
core +1 more source
Trends in anticoagulant prescribing: a review of local policies in English primary care
Background Oral anticoagulants are prescribed for stroke prophylaxis in patients with atrial fibrillation, which is the most common heart arrhythmia worldwide. The vitamin K antagonist (VKA) warfarin is a long-established anticoagulant.
Katherine H. Ho, M. van Hove, G. Leng
semanticscholar +1 more source
BackgroundThe nonvitamin K antagonist oral anticoagulants have recently become available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on real‐life patient experience, including bleeding risk, are lacking.
Morten Lamberts+8 more
doaj +1 more source
Anticoagulation in cirrhosis [PDF]
The Authors review and comment a recent publication by Senzolo et al.
VILLA, Erica, N. De Maria
openaire +4 more sources
The Anticoagulant and Nonanticoagulant Properties of Heparin
Heparins represent one of the most frequently used pharmacotherapeutics. Discovered around 1926, routine clinical anticoagulant use of heparin was initiated only after the publication of several seminal papers in the early 1970s by the group of Kakkar ...
D. Beurskens+5 more
semanticscholar +1 more source
BackgroundWe studied the concomitant use of single antiplatelet therapy (SAPT) on the efficacy and safety of the anti‐Xa agent edoxaban in patients with atrial fibrillation (AF). Methods and ResultsENGAGE AF‐TIMI 48 was a randomized trial that compared 2
Haiyan Xu+9 more
doaj +1 more source
Background: Targeting factor XI (FXI) is a promising therapeutic strategy for the treatment and prevention of thrombosis without increasing the risk of bleeding. Here, we assessed the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of SHR2285, a
Rui Chen+7 more
doaj +1 more source
Coronavirus disease (COVID‐19) is associated with a high incidence of thrombosis and mortality despite standard anticoagulant thromboprophylaxis. There is equipoise regarding the optimal dose of anticoagulant intervention in hospitalized patients with ...
T. Tritschler+33 more
semanticscholar +1 more source